Papers and Presentations
Dr. Roger Chafe, director of pediatric research in the Faculty of Medicine, is the lead author of an editorial titled The Need for Public Engagement in Choosing Health Priorities, released recently in the CMAJ.
Dr. Christopher Kovacs, Faculty of Medicine, is a co-author of the book Dietary Reference Intakes for Calcium and Vitamin D, Institute of Medicine, 2010. This was co-authored with the other 13 members of the Institute of Medicine panel. The online publication was Nov. 30 and the hard copy will be published in February 2011. Dr. Kovacs is also a co-author of the 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. Journal of Clinical Endocrinology and Metabolism. Online publication Nov. 29; print publication will be in the January 2011 issue.
Dr. Atanu Sarkar, Environmental and Occupational Health, Division of Community Health and Humanities, Faculty of Medicine, presented a paper at the Canadian Conference on Global Health, recently held in Ottawa (Oct. 31-Nov. 3). The paper is titled Modern Agriculture Practice and Emergence of New Health Crisis in Rural India. The paper highlights the rise of overweight/obesity in the rural India due to changing dietary pattern, and life style and the roles of modern agriculture practice in this epidemiological transition. The findings have opened a new debate on population health in the context of the developing countries.
Dr. Terry-Lynn Young and her colleagues in the Faculty of Medicine are authors of a paper just published online in the European Journal of Human Genetics. The paper, titled A Novel, Non-stop Mutation in FOXE3 Causes an Autosomal Dominant Form of Variable Anterior Segment Dysgenesis including Peters Anomaly, identifies the genetics basis of a rare eye disease found in Newfoundland families. PhD student Lance Doucette solved the molecular puzzle and Drs. Jane Green and Bridget Fernandez identified the family and provided clinical expertise to the study. The discovery of the molecular etiology of this rare eye disease has immediate clinical utility as it provides presymptomatic and diagnostic testing to family members.